RU2013109455A - TRANSDERMAL AGENT CONTAINING SILICON-ORGANIC NATURE NANOCONTAINERS FOR TREATMENT OF PSYCHO-EMOTIONAL DISORDERS - Google Patents

TRANSDERMAL AGENT CONTAINING SILICON-ORGANIC NATURE NANOCONTAINERS FOR TREATMENT OF PSYCHO-EMOTIONAL DISORDERS Download PDF

Info

Publication number
RU2013109455A
RU2013109455A RU2013109455/15A RU2013109455A RU2013109455A RU 2013109455 A RU2013109455 A RU 2013109455A RU 2013109455/15 A RU2013109455/15 A RU 2013109455/15A RU 2013109455 A RU2013109455 A RU 2013109455A RU 2013109455 A RU2013109455 A RU 2013109455A
Authority
RU
Russia
Prior art keywords
nanocontainers
psycho
treatment
agent containing
containing silicon
Prior art date
Application number
RU2013109455/15A
Other languages
Russian (ru)
Other versions
RU2560668C2 (en
Inventor
Игорь Александрович Базиков
Игорь Викторович Боев
Original Assignee
Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" filed Critical Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии"
Priority to RU2013109455/15A priority Critical patent/RU2560668C2/en
Publication of RU2013109455A publication Critical patent/RU2013109455A/en
Application granted granted Critical
Publication of RU2560668C2 publication Critical patent/RU2560668C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Седативное трансдермальное средство, включающее растительные экстракты, отличающееся тем, что экстракты инкапсулированы в кремнийорганические наноконтейнеры с 10% содержанием в геле, а экстракты пустырника, зверобоя гинкго билоба в соотношении 1:1.Sedative transdermal product, including plant extracts, characterized in that the extracts are encapsulated in organosilicon nanocontainers with a 10% gel content, and motherwort, St. John's wort ginkgo biloba extracts in a 1: 1 ratio.

Claims (1)

Седативное трансдермальное средство, включающее растительные экстракты, отличающееся тем, что экстракты инкапсулированы в кремнийорганические наноконтейнеры с 10% содержанием в геле, а экстракты пустырника, зверобоя гинкго билоба в соотношении 1:1. Sedative transdermal product, including plant extracts, characterized in that the extracts are encapsulated in organosilicon nanocontainers with a 10% gel content, and motherwort, St. John's wort ginkgo biloba extracts in a 1: 1 ratio.
RU2013109455/15A 2013-03-04 2013-03-04 Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders RU2560668C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013109455/15A RU2560668C2 (en) 2013-03-04 2013-03-04 Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013109455/15A RU2560668C2 (en) 2013-03-04 2013-03-04 Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders

Publications (2)

Publication Number Publication Date
RU2013109455A true RU2013109455A (en) 2014-09-10
RU2560668C2 RU2560668C2 (en) 2015-08-20

Family

ID=51539813

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013109455/15A RU2560668C2 (en) 2013-03-04 2013-03-04 Transdermal sedative pharmaceutical gel for treatment of psychoemotional disorders

Country Status (1)

Country Link
RU (1) RU2560668C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI389709B (en) * 2005-12-01 2013-03-21 Novartis Ag Transdermal therapeutic system
RU2408384C2 (en) * 2006-04-19 2011-01-10 Джианксан ЛЬЮ Chinese medicinal composition, method for preparing and administration
RU2383328C2 (en) * 2007-07-02 2010-03-10 Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" Transdermal gel for area around eyes "silky touch"
RU2391996C1 (en) * 2008-12-22 2010-06-20 Ольга Александровна Субботина Remedy for treatment of cardiovascular diseases

Also Published As

Publication number Publication date
RU2560668C2 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
EA201391119A1 (en) DELIVERY SYSTEMS OF NANOPARTICLES, THEIR RECEIVING AND APPLICATION
UA109650C2 (en) BIS-ARLYZED ARILTRIAZOLONS AND THEIR APPLICATIONS
WO2015048689A8 (en) Inhibitors of bruton's tyrosine kinase
MA38399A1 (en) Formulation in tablet form, useful for treating acute heart failure and chronic heart failure
MX2015009106A (en) Solid solution compositions and use in severe pain.
PL2928484T3 (en) Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions
PH12015502535A1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
NZ630367A (en) Methods of treatment of pediatric solid tumor
FR3028753B1 (en) AQUEOUS OR HYDRO-ALCOHOLIC GEL OF SYNTHETIC PHYLLOSILICATES AS A VISCOSING AGENT, MATIFIING AND / OR HOMOGENIZING APPLICATION
EA201591925A1 (en) THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
EA201891608A1 (en) DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN
WO2015130554A3 (en) Dosage and administration of anti-igf-1r, anti-erbb3 bispecific antibodies, uses thereof and methods of treatment therewith
TR201910866T4 (en) Combined preparations for cancer treatment.
EA201491691A1 (en) UNITS OF NANOPARTICLES CONTAINING OSTEOPONTIN AND CALCIUM AND / OR STRONTIUM PARTY
MA38253A1 (en) Compositions comprising vortioxetine and donepezil
EA201891612A1 (en) DERIVATIVES 3- (CARBOXYMETHYL) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DEAN
MX2023007706A (en) Nanoparticles for use as a therapeutic vaccine.
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EA201891611A1 (en) DERIVATIVES 3 - ((HETERO-) Aryl) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN
MA39447B1 (en) Pirlindole or its pharmaceutically acceptable salts for use in medicine
MY177827A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
CL2012003209A1 (en) Synthesis method of poly (lactic-glycolic acid) nanoparticles (plga) with pentoxifylline; pharmaceutical composition comprising nanoparticles of pest with pentoxifylline; and use of the nanoparticles loaded with pentoxifylline in the treatment of relief and prevention of chronic pain.
TR201007110A2 (en) Combinations with synergistic effects

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20151005

NF4A Reinstatement of patent

Effective date: 20170613

PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20180206

QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20190301

Effective date: 20190301